Responses
Oral Presentations
THURSDAY, 13 JUNE 2019
Psoriatic arthritis: old and new drugs and how to deal with them?
OP0108 DUAL NEUTRALISATION OF IL-17A AND IL-17F WITH BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSA: OVERALL AND TNF-INHIBITOR-NAÏVE POPULATION RESULTS FROM A 48-WEEK PHASE 2B RANDOMISED STUDY
Compose a Response to This Article
Other responses
No responses have been published for this article.